Forgot your password?

Forgot your username?

database > company
NeoStem
Biotech Specialty Pharma
420 Lexington Avenue Suite 450
New York, NY 10170 USA
phone:212-584-4180
fax:646-514-7787
Symbol NBS
Exchange AMEX
Founded 2006
Employees 600
www.neostem.com
Research Sector Biotech Specialty Pharma
Summary Description
International biopharmaceutical company with a leading position as a stem cell based company with both manufacturing and therapeutic divisions.
Management
Robin Smith, MD MBA, CEO & Chairman of the Board; Jason Kolbert, MBA, Vice President, Strategic Business Development
Ownership
Financials Mkt Cap :17


* numbers in thousands
 

Keywords
Stem cell harvesting, stem cell bank, China

Comment | Printable Version | Modify profile |
Updated: May 23, 2012

Description
NeoStem, Inc. is an international biopharmaceutical company with product and service revenues, global research and development capabilities and operations in three distinct business units: (i) U.S. adult stem cells, (ii) China adult stem cells, (iii) China pharmaceuticals. These business units are expected to provide platforms for the accelerated development and commercialization of innovative technologies and products in both the U.S. and China.
Products / Services
Stem Cell Therapy

Stem Cell Banking

Manufacturing of Generic Pharmaceuticals

Technology / Differentiation
A significant development by Neostem has been a technological platform to harvest and then preserve an individual's stem cells, thereby serving as a stem cell bank for customers. The company's proprietary technology, including the very small embryonic stem cell VSEL(TM) Technology, enables the harvesting of a patient's stem cells by a simple procedure and then enables the cryo-preservation of the harvested stem cells for storage.
Market / Customers
Adults in US & China

Over 150 Billion Dollars annual business worldwide stem cell therapy and pharmaceuticals in China

Status
Revenue generating with drugs in pipeline, clinical trials and mature stem cell therapy with early stage stem cell research and development.